Harpoon Therapeutics (NASDAQ:HARP) Target Raised by Citigroup Inc to $24.00

0
43
Stock Market Data/chart illustration

Harpoon Therapeutics stock has undergone multiple analysts rating changes in the recent past.  Harpoon Therapeutics stock Target Raised by   Citigroup Inc on 6/30/2020. In a note to investors, the firm issued a new target price of $24.00. The analysts previously had $23.00 target price. Citigroup Inc’s price target would indicate a potential upside of 45.54% from the stock’s previous close.

Shares of Harpoon Therapeutics traded down -$0.24 on Tuesday, reaching $16.25. 58272 shares of the stock traded hands, compared to its average volume of 260871. Shares of were trading at $16.25 on Tuesday. The firm’s 50 day moving average is $$16.57 and its 200 day moving average is $14.92.Harpoon Therapeutics  has a 12 month low of $16.08 and a 12 month high of $25.02. While on yearly highs and lows, Harpoon Therapeutics today has traded high as $16.85 and has touched $16.08 on the downward trend.

Harpoon Therapeutics Earnings and What to expect: 

Harpoon Therapeutics last issued its earnings results on May 6th, 2020. The reported ($0.51) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.40) by $0.11. The company had revenue of $3.30 million for the quarter, compared to analysts’ expectations of $7.58 million. Harpoon Therapeutics has generated ($2.55) earnings per share over the last year. Harpoon Therapeutics has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, August 3rd, 2020 based off prior year’s report dates.

Earnings for Harpoon Therapeutics are expected to remain at ($2.02) per share in the coming year. The P/E ratio of Harpoon Therapeutics is -7.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Harpoon Therapeutics is -7.35, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Harpoon Therapeutics has a P/B Ratio of 4.29. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Latest Insiders Trading and Volume : 

  • Insider Ownership Percentage: 34.90%
  • On 5/27/2020 Major Shareholder Bioscience Plc Arix Sell 12,064 at average share price of $22.39 which equates to $270,112.96 in money value.
  • On 5/18/2020 Insider Natalie Sacks Sell 1,522 at average price of  $14.77 with total value of : Not Data Available
  • On 5/11/2020 Insider Holger Wesche Sell 1,000 at average price of  $14.07 with total value of : $14,070.00
  • See More Analyst Rating at: RATING

Other Analyst’s rating for Harpoon Therapeutics

  • 6/2/2020 – Harpoon Therapeutics was upgraded by analysts at BidaskClub from a “hold” rating to a “buy” rating.
  • 6/1/2020 – Harpoon Therapeutics had its price target raised by analysts at Wedbush from $26.00 to $36.00. They now have an “outperform” rating on the stock.
  • 6/1/2020 – Harpoon Therapeutics had its “buy” rating re-affirmed by analysts at HC Wainwright.
  • 5/29/2020 – Harpoon Therapeutics had its price target raised by analysts at Roth Capital from $25.00 to $31.00. They now have a “buy” rating on the stock.
  • See More Analyst Rating at: RATING

Other rating updates by Citigroup Inc: 

  • 6/30/2020 – Intercept Pharmaceuticals was upgraded by analysts at Citigroup Inc from a “neutral” rating to a “buy” rating.
  • 6/30/2020 – Apellis Pharmaceuticals had its price target lowered by analysts at Citigroup Inc from $56.00 to $54.00. They now have a “buy” rating on the stock.
  • 6/30/2020 – DISH Network had its price target raised by analysts at Citigroup Inc from $35.00 to $39.00. They now have a “buy” rating on the stock.
  • 6/30/2020 – Extra Space Storage had its price target raised by analysts at Citigroup Inc from $100.00 to $105.00. They now have a “buy” rating on the stock.
  • See More Analyst Rating at: RATING

Harpoon Therapeutics (NASDAQ:HARP) Moving Average Technical Analysis

5 day Moving Average is $$17.09 And 5 day price change is -$1.49 (-8.37%)  with average volume for 5 day average is 193,233. While technical analysis for average 20 days shows significant difference, 20 day moving average is  $17.69 and 20 day price change is -$1.97 (-10.78%) and average 20 day moving volume is 135,208. 50 day moving average is $16.57  and 50 day price change is $3.30 ( 25.37%)  and with average volume for 50 days is : 191,281. 200 day moving average is $14.92  and 200 day price change is $0.03 (0.18%)  and with average volume for 200 days is : 121,549.

See More Analyst Rating at: RATING